Page 12 - கேம்பிரிட்ஜ் ஒன்றுபட்டது கிஂக்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Search jobs HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration CHENGDU, China (BUSINESS WIRE) HitGen (688222.SH) today announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc. to identify small molecule Hits against previous known-to-be undruggable targets and novel E3 ligase. HitGen will apply its platform technology, based on the design, synthesis and screening of DNA-encoded libraries (DEL) to discover compounds that bind to certain targets. The identified compounds will be exclusively licensed to UPPTHERA for further development. Under the terms of the agreement, HitGen will receive an undisclosed upfront payment, success fee, license/milestone fee from UPPTHERA.

Cholla namdoSouth koreaUnited statesUnited kingdomSiwoo choiJin liVernalis rd ltdHitgen incChief executive officerProteolysis targeting chimeraShanghai stock exchangeCambridge united kingdomNorth americaதெற்கு கொரியாஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்